Table 1:

Planned Dose Levels

	Dose and Schedule (28 day cycles)		Number of subjects enrolled
Dose Level	5-Azacitidine	Romidepsin	Phase I	Expansion
Level −1†	100mg daily days 1–14	8mg/m2 days 8 and 15	-	-
Level 1	200mg daily days 1–14	8mg/m2 days 8 and 15	3	-
Level 2	300mg daily days 1–14	8mg/m2 days 8 and 15	8	4
Level 3	300mg daily days 1–21	8mg/m2 days 8 and 15	3	-
Level 4‡	MTD daily days 1–21	8mg/m2 days 8, 15, and 22	-	-

^†Subjects would only be enrolled in Level −1 if >2 DLTs in Level 1

^‡Level 4 was optional and based on discussions between the study investigator and Celgene was not opened to enrollment.